Antihistamines likely offer no meaningful benefit for eczema and may increase harms

Adding oral antihistamines to existing eczema treatments is unlikely to lead to clinically important reductions in eczema and itch severity and may not reduce sleep disturbance or flare-ups, finds a review of the latest trial evidence published by The BMJ today.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup